8 / 1082
Focus on lung cancer: What a radiotherapy department should offer their patients ..................... Abs. 385
How to write a research proposal for a grant? ....................................................................... Abs. 386
Symposium
Rectal cancer – prediction and individualisation ...............................................................Abs. 387-389
Radiotherapy of brain tumours . ....................................................................................Abs. 390-392
MR guided radiotherapy: the new standard of care in 10 years time ...................................Abs. 393-396
Symposium with Proffered Papers
Novel approaches in head and neck tumour control .........................................................Abs. 397-400
Symposium
Experimental therapies ................................................................................................Abs. 401-403
Adaptive radiotherapy (both anatomical and ‘functional’ changes) ......................................Abs. 404-406
Focus on lung cancer: What a radiotherapy department should offer their patients ...............Abs. 407-409
Education and research grants ......................................................................................Abs. 410-414
Poster Viewing
Session 9: Dosimetry ..................................................................................................Abs. 415-423
Proffered Papers
Upper and Lower GI ....................................................................................................Abs. 424-429
Joint Symposium
ESTRO-ESR: Radiomics and imaging databases for precision radiation oncology ...................Abs. 430-433
Symposium with Proffered Papers
Novel approaches in prostate tumour control ..................................................................Abs. 434-436
Proffered Papers
New technologies for imaging and therapy .....................................................................Abs. 437-442
Optimatisation algorithms for treatment planning ............................................................Abs. 443-448
Planning and quality assurance .....................................................................................Abs. 449-454
Poster Viewing
Session 10: RTT .........................................................................................................Abs. 456-462
Award Lecture
Donal Hollywood Award ..................................................................................................... Abs. 463
Proffered Papers
Highlights of proffered papers . .....................................................................................Abs. 464-467
Symposium
Non-rectal GI tumours: key open questions to be answered from
(and for) the radiation oncologist! .................................................................................Abs. 469-471
Joint Symposium
ESTRO-RANZCR: Big data to better radiotherapy .............................................................Abs. 472-475
Symposium
Locally advanced breast cancer . ...................................................................................Abs. 476-478
Symposium with Proffered Papers
Novel approaches in thoracic tumour treatment . .............................................................Abs. 479-482
Proffered Papers
Inter-fraction motion management ................................................................................Abs. 483-491
Symposium
Focus on prostate cancer: what is the best of radiotherapy
we need to treat our patients with . ...............................................................................Abs. 492-494
Young ESTRO meets ESTRO School ...............................................................................Abs. 495-501
Poster Viewing
Session 11: Head and neck and CNS .............................................................................Abs. 502-511
Proffered Papers
CNS ..........................................................................................................................Abs. 512-517
Symposium
Patient Reported Outcomes (PROs) in radiotherapy ..........................................................Abs. 518-520
Proffered Papers
Oligometastatic disease ...............................................................................................Abs. 521-526
Symposium with Proffered Papers
Novel approaches in colorectal tumour control ................................................................Abs. 527-529